FDA inspection reveals critical supply chain vulnerabilities

Similarly, based on information compiled by GlobalData, Novartis manufactures diclofenac sodium for Voltaren at facilities in the UK and Switzerland, supplementing internal production with external suppliers including Hetero. This diversification provides some buffer against supply disruptions, but regulatory events still trigger urgent supply chain reviews and vendor qualification processes.Pfizer's Paxlovid supply chain illustrates the complexity of modern pharmaceutical manufacturing. The company produce ...